habener glp-1 TIME100 Health: Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst Tang Prize | Laureates |

In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority

Quick Answer: GLP-1-related bloating can be reduced through smaller frequent meals, avoiding high-fat and gas-producing foods, eating slowly, gentle post-meal walking, and dose adjustment strategies under medical supervision

Helaas mogen wij door de strenge EU-wetgeving maar beperkt informatie geven over de werking van producten

GLP-1 receptor agonist medications like semaglutide and tirzepatide mimic and extend these effects far beyond what the body produces naturally